CO-DIAGNOSTICS INC (CODX) Stock Price, Quote, News and Overview
NASDAQ:CODX - Nasdaq - US1897631057 - Common Stock - Currency: USD
CODX Quote, Performance and Key Statistics
0.2617
-0.02 (-6.4%)
The current stock price of CODX is 0.2617 USD. In the past month the price increased by 2.63%. In the past year, price decreased by -82.2%.
CODX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.82 | 231.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.67 | 182.56B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.52 | 149.87B | ||
| SYK | STRYKER CORP | 29.97 | 143.52B | ||
| MDT | MEDTRONIC PLC | 15.7 | 110.73B | ||
| BDX | BECTON DICKINSON AND CO | 11.95 | 48.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.4 | 43.31B | ||
| IDXX | IDEXX LABORATORIES INC | 45.96 | 42.46B | ||
| RMD | RESMED INC | 27.94 | 37.20B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.5 | 32.64B | ||
| DXCM | DEXCOM INC | 48.48 | 31.37B | ||
| STE | STERIS PLC | 25.23 | 23.15B |
Related stock screener links
About CODX
Company Profile
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 132 full-time employees. The company went IPO on 2017-07-12. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The firm also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. The company is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Company Info
CO-DIAGNOSTICS INC
4049 S Highland Dr
Salt Lake City UTAH 84109 US
CEO: Dwight Egan
Employees: 132
Phone: 18012789769
CO-DIAGNOSTICS INC / CODX FAQ
What is the stock price of CO-DIAGNOSTICS INC today?
The current stock price of CODX is 0.2617 USD. The price decreased by -6.4% in the last trading session.
What is the ticker symbol for CO-DIAGNOSTICS INC stock?
The exchange symbol of CO-DIAGNOSTICS INC is CODX and it is listed on the Nasdaq exchange.
On which exchange is CODX stock listed?
CODX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CO-DIAGNOSTICS INC stock?
8 analysts have analysed CODX and the average price target is 5.61 USD. This implies a price increase of 2043.68% is expected in the next year compared to the current price of 0.2617. Check the CO-DIAGNOSTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CO-DIAGNOSTICS INC worth?
CO-DIAGNOSTICS INC (CODX) has a market capitalization of 8.82M USD. This makes CODX a Nano Cap stock.
How many employees does CO-DIAGNOSTICS INC have?
CO-DIAGNOSTICS INC (CODX) currently has 132 employees.
What are the support and resistance levels for CO-DIAGNOSTICS INC (CODX) stock?
CO-DIAGNOSTICS INC (CODX) has a resistance level at 0.28. Check the full technical report for a detailed analysis of CODX support and resistance levels.
Is CO-DIAGNOSTICS INC (CODX) expected to grow?
The Revenue of CO-DIAGNOSTICS INC (CODX) is expected to decline by -88.53% in the next year. Check the estimates tab for more information on the CODX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CO-DIAGNOSTICS INC (CODX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CODX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CODX, evaluating the profitability, health, valuation and growth aspects
- CO-DIAGNOSTICS INC (CODX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CO-DIAGNOSTICS INC (CODX) Sales and EPS estimates to see what analysts future expectations are.
- CO-DIAGNOSTICS INC (CODX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CO-DIAGNOSTICS INC (CODX) Insider and Institutional Ownership to learn about the owners and their transactions.
- CO-DIAGNOSTICS INC (CODX) Stock Chart to make your own analysis
- CO-DIAGNOSTICS INC (CODX) Latest news and press-releases to stay up to date.
Does CO-DIAGNOSTICS INC (CODX) stock pay dividends?
CODX does not pay a dividend.
When does CO-DIAGNOSTICS INC (CODX) report earnings?
CO-DIAGNOSTICS INC (CODX) will report earnings on 2025-08-06.
What is the Price/Earnings (PE) ratio of CO-DIAGNOSTICS INC (CODX)?
CO-DIAGNOSTICS INC (CODX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.06).
What is the Short Interest ratio of CO-DIAGNOSTICS INC (CODX) stock?
The outstanding short interest for CO-DIAGNOSTICS INC (CODX) is 1.26% of its float. Check the ownership tab for more information on the CODX short interest.
CODX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CODX. When comparing the yearly performance of all stocks, CODX is a bad performer in the overall market: 98.09% of all stocks are doing better.
CODX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CODX. The financial health of CODX is average, but there are quite some concerns on its profitability.
CODX Financial Highlights
Over the last trailing twelve months CODX reported a non-GAAP Earnings per Share(EPS) of -1.06. The EPS increased by 19.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -65.02% | ||
| ROE | -74.83% | ||
| Debt/Equity | 0 |
CODX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to CODX. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 17.86% and a revenue growth -88.53% for CODX